Neural Stem Cells for Early Ischemic Stroke

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Jul 24

PMID 34299322

Citations 16

Authors

Milton H Hamblin

Jean-Pyo Lee

Affiliations

Soon will be listed here.

Abstract

Clinical treatments for ischemic stroke are limited. Neural stem cell (NSC) transplantation can be a promising therapy. Clinically, ischemia and subsequent reperfusion lead to extensive neurovascular injury that involves inflammation, disruption of the blood-brain barrier, and brain cell death. NSCs exhibit multiple potentially therapeutic actions against neurovascular injury. Currently, tissue plasminogen activator (tPA) is the only FDA-approved clot-dissolving agent. While tPA's thrombolytic role within the vasculature is beneficial, tPA's non-thrombolytic deleterious effects aggravates neurovascular injury, restricting the treatment time window (time-sensitive) and tPA eligibility. Thus, new strategies are needed to mitigate tPA's detrimental effects and quickly mediate vascular repair after stroke. Up to date, clinical trials focus on the impact of stem cell therapy on neuro-restoration by delivering cells during the chronic stroke stage. Also, NSCs secrete factors that stimulate endogenous repair mechanisms for early-stage ischemic stroke. This review will present an integrated view of the preclinical perspectives of NSC transplantation as a promising treatment for neurovascular injury, with an emphasis on early-stage ischemic stroke. Further, this will highlight the impact of early sub-acute NSC delivery on improving short-term and long-term stroke outcomes.

Citing Articles

Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases.

Tang X, Deng P, Li L, He Y, Wang J, Hao D Stem Cell Res Ther. 2024; 15(1):482.

PMID: 39696712 PMC: 11656587. DOI: 10.1186/s13287-024-04089-1.

Cocaine amphetamine-regulated transcription peptide inhibits apoptosis in oxygen-glucose deprived neural stem cells.

Zhang L, Chen S, Zou R, Shu X, Zhang J, He X Front Neurosci. 2024; 18:1424719.

PMID: 39228411 PMC: 11368759. DOI: 10.3389/fnins.2024.1424719.

Polymeric nanocarriers delivery systems in ischemic stroke for targeted therapeutic strategies.

Zhu L, Zhong W, Meng X, Yang X, Zhang W, Tian Y J Nanobiotechnology. 2024; 22(1):424.

PMID: 39026255 PMC: 11256638. DOI: 10.1186/s12951-024-02673-4.

Emerging strategies for nerve repair and regeneration in ischemic stroke: neural stem cell therapy.

Wang S, He Q, Qu Y, Yin W, Zhao R, Wang X Neural Regen Res. 2024; 19(11):2430-2443.

PMID: 38526280 PMC: 11090435. DOI: 10.4103/1673-5374.391313.

Comparative study of the efficacy of intra-arterial and intravenous transplantation of human induced pluripotent stem cells-derived neural progenitor cells in experimental stroke.

Cherkashova E, Namestnikova D, Leonov G, Gubskiy I, Sukhinich K, Melnikov P PeerJ. 2023; 11:e16358.

PMID: 38025691 PMC: 10640846. DOI: 10.7717/peerj.16358.

References

Chin M, Mason M, Xie W, Volinia S, Singer M, Peterson C . Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell. 2009; 5(1):111-23. PMC: 3448781. DOI: 10.1016/j.stem.2009.06.008. View

Chambers S, Fasano C, Papapetrou E, Tomishima M, Sadelain M, Studer L . Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009; 27(3):275-80. PMC: 2756723. DOI: 10.1038/nbt.1529. View

Bond A, Ming G, Song H . Adult Mammalian Neural Stem Cells and Neurogenesis: Five Decades Later. Cell Stem Cell. 2015; 17(4):385-95. PMC: 4683085. DOI: 10.1016/j.stem.2015.09.003. View

Newman A, Cooper J . Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell. 2010; 7(2):258-62. DOI: 10.1016/j.stem.2010.06.016. View

Reubinoff B, Itsykson P, Turetsky T, Pera M, Reinhartz E, Itzik A . Neural progenitors from human embryonic stem cells. Nat Biotechnol. 2001; 19(12):1134-40. DOI: 10.1038/nbt1201-1134. View

Yemisci M, Gursoy-Ozdemir Y, Vural A, Can A, Topalkara K, Dalkara T . Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med. 2009; 15(9):1031-7. DOI: 10.1038/nm.2022. View

He J, Sussman E, Steinberg G . Revisiting Stem Cell-Based Clinical Trials for Ischemic Stroke. Front Aging Neurosci. 2020; 12:575990. PMC: 7767918. DOI: 10.3389/fnagi.2020.575990. View

Kim J, Efe J, Zhu S, Talantova M, Yuan X, Wang S . Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci U S A. 2011; 108(19):7838-43. PMC: 3093517. DOI: 10.1073/pnas.1103113108. View

van Velthoven C, Kavelaars A, van Bel F, Heijnen C . Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun. 2009; 24(3):387-93. DOI: 10.1016/j.bbi.2009.10.017. View

10.

Del Zoppo G . The neurovascular unit, matrix proteases, and innate inflammation. Ann N Y Acad Sci. 2010; 1207:46-9. PMC: 4547552. DOI: 10.1111/j.1749-6632.2010.05760.x. View

11.

Bouet V, Boulouard M, Toutain J, Divoux D, Bernaudin M, Schumann-Bard P . The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice. Nat Protoc. 2009; 4(10):1560-4. DOI: 10.1038/nprot.2009.125. View

12.

Staerk J, Dawlaty M, Gao Q, Maetzel D, Hanna J, Sommer C . Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell. 2010; 7(1):20-4. PMC: 2917234. DOI: 10.1016/j.stem.2010.06.002. View

13.

Venkat P, Chopp M, Chen J . New insights into coupling and uncoupling of cerebral blood flow and metabolism in the brain. Croat Med J. 2016; 57(3):223-8. PMC: 4937223. DOI: 10.3325/cmj.2016.57.223. View

14.

Lledo P, Alonso M, Grubb M . Adult neurogenesis and functional plasticity in neuronal circuits. Nat Rev Neurosci. 2006; 7(3):179-93. DOI: 10.1038/nrn1867. View

15.

Amiri H, Bluhmki E, Bendszus M, Eschenfelder C, Donnan G, Leys D . European Cooperative Acute Stroke Study-4: Extending the time for thrombolysis in emergency neurological deficits ECASS-4: ExTEND. Int J Stroke. 2016; 11(2):260-7. DOI: 10.1177/1747493015620805. View

16.

Kulik T, Kusano Y, Aronhime S, Sandler A, Winn H . Regulation of cerebral vasculature in normal and ischemic brain. Neuropharmacology. 2008; 55(3):281-8. PMC: 2896303. DOI: 10.1016/j.neuropharm.2008.04.017. View

17.

Noble L, Donovan F, Igarashi T, Goussev S, Werb Z . Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci. 2002; 22(17):7526-35. PMC: 2792199. View

18.

Gendron A, Teitelbaum J, Cossette C, Nuara S, Dumont M, Geadah D . Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. Brain Res. 2002; 955(1-2):85-97. DOI: 10.1016/s0006-8993(02)03368-1. View

19.

Sun Y, Jin K, Xie L, Childs J, Mao X, Logvinova A . VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003; 111(12):1843-51. PMC: 161428. DOI: 10.1172/JCI17977. View

20.

Abbott N . Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat. 2002; 200(6):629-38. PMC: 1570746. DOI: 10.1046/j.1469-7580.2002.00064.x. View